Unicycive Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
GREAT POINT PARTNERS LLC | 05/15/2025 | 10.98 M | $6.31 M | 0.00% | 1.64% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 9.39 M | $5.40 M | -9.62% | 1.40% |
VIVO CAPITAL, LLC | 05/12/2025 | 11.37 M | $6.54 M | 14.04% | 0.97% |
OCTAGON CAPITAL ADVISORS LP | 05/16/2025 | 10.00 M | $5.75 M | 0.00% | 0.86% |
LOGOS GLOBAL MANAGEMENT LP | 05/15/2025 | 5.08 M | $2.92 M | 0.00% | 0.76% |
WALLEYE CAPITAL LLC | 05/14/2025 | 4.09 M | $2.35 M | -18.11% | 0.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 2.41 M | $1.39 M | -2.94% | 0.21% |
ACUTA CAPITAL PARTNERS, LLC | 05/15/2025 | 2.35 M | $1.35 M | 2.17% | 0.20% |
ALYESKA INVESTMENT GROUP, L.P. | 05/15/2025 | 1.75 M | $1.01 M | 0.00% | 0.15% |
VANGUARD GROUP INC | 05/09/2025 | 1.21 M | $697.15 K | 6.52% | 0.10% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 579.20 K | $332.98 K | 10.43% | 0.05% |
STATE STREET CORP | 05/15/2025 | 125.24 K | $72.00 K | 0.00% | 0.01% |
XTX TOPCO LTD | 05/08/2025 | 123.23 K | $70.85 K | -28.13% | 0.01% |
NORTHERN TRUST CORP | 05/13/2025 | 107.85 K | $62.00 K | 85.37% | 0.01% |
BLACKROCK, INC. | 05/02/2025 | 83.24 K | $47.86 K | 15.18% | 0.01% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 73.48 K | $42.24 K | -0.18% | 0.01% |
CREATIVE PLANNING | 05/15/2025 | 25.91 K | $14.90 K | 14.27% | 0.00% |
VIRTU FINANCIAL LLC | 05/12/2025 | 38.87 K | $22.00 K | 100.00% | 0.00% |
CANTOR FITZGERALD, L. P. | 05/15/2025 | 32.97 K | $18.96 K | 100.00% | 0.00% |
MORGAN STANLEY | 05/15/2025 | 22.27 K | $12.80 K | 345.32% | 0.00% |
HRT FINANCIAL LP | 05/15/2025 | 17.82 K | $10.00 K | -19.50% | 0.00% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 04/22/2025 | 15.50 K | $8.91 K | 0.00% | 0.00% |
HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 14.84 K | $8.53 K | 100.00% | 0.00% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 12.04 K | $6.92 K | 100.00% | 0.00% |
UBS GROUP AG | 05/13/2025 | 9.55 K | $5.49 K | 955,100.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 428 | $246 | 5.42% | 0.00% |
JPMORGAN CHASE & CO | 05/12/2025 | 184 | $106 | -7.54% | 0.00% |
BOGART WEALTH, LLC | 05/02/2025 | 60 | $34 | 0.00% | 0.00% |
05/02/2025 | 25 | $14 | -48.98% | 0.00% | |
CITIGROUP INC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 04/30/2025 | 0 | $0 | -100.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
ALTIUM CAPITAL MANAGEMENT LP | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
SOA WEALTH ADVISORS, LLC. | 04/14/2025 | 0 | $0 | -100.00% | 0.00% |
FAMILY WEALTH GROUP, LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
Unicycive Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Unicycive Therapeutics, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 11.37 M
GREAT POINT PARTNERS LLC: 10.98 M
Octagon Capital Advisors LP: 10 M
Nantahala Capital Management, LLC: 9.39 M
Logos Global Management LP: 5.08 M
Walleye Capital LLC: 4.09 M
5.13% of Unicycive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 60.00 M shares in the last 24 months. This purchase volume represents approximately $275.99 M in transactions.